These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 32926944)

  • 21. Liposomal doxorubicin as targeted delivery platform: Current trends in surface functionalization.
    Makwana V; Karanjia J; Haselhorst T; Anoopkumar-Dukie S; Rudrawar S
    Int J Pharm; 2021 Jan; 593():120117. PubMed ID: 33259901
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Epidermal growth factor receptor (EGFR)-targeted immunoliposomes mediate specific and efficient drug delivery to EGFR- and EGFRvIII-overexpressing tumor cells.
    Mamot C; Drummond DC; Greiser U; Hong K; Kirpotin DB; Marks JD; Park JW
    Cancer Res; 2003 Jun; 63(12):3154-61. PubMed ID: 12810643
    [TBL] [Abstract][Full Text] [Related]  

  • 23. EGFR-targeted immunoliposomes derived from the monoclonal antibody EMD72000 mediate specific and efficient drug delivery to a variety of colorectal cancer cells.
    Mamot C; Ritschard R; Küng W; Park JW; Herrmann R; Rochlitz CF
    J Drug Target; 2006 May; 14(4):215-23. PubMed ID: 16777680
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficient intracellular delivery of 5-fluorodeoxyuridine into colon cancer cells by targeted immunoliposomes.
    Koning GA; Kamps JA; Scherphof GL
    Cancer Detect Prev; 2002; 26(4):299-307. PubMed ID: 12430634
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Novel drug delivery liposomes targeted with a fully human anti-VEGF165 monoclonal antibody show superior antitumor efficacy in vivo.
    Shi C; Cao H; He W; Gao F; Liu Y; Yin L
    Biomed Pharmacother; 2015 Jul; 73():48-57. PubMed ID: 26211582
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Multi-functional vesicles for cancer therapy: The ultimate magic bullet.
    Tavano L; Muzzalupo R
    Colloids Surf B Biointerfaces; 2016 Nov; 147():161-171. PubMed ID: 27500359
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Urea immunoliposome inhibits human vascular endothelial cell proliferation for hemangioma treatment.
    Wang Z; Li J; Xu X; Duan X; Cao G
    World J Surg Oncol; 2013 Nov; 11():300. PubMed ID: 24266957
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immunoliposomes: a promising approach to targeting cancer therapy.
    Bendas G
    BioDrugs; 2001; 15(4):215-24. PubMed ID: 11437687
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunoliposomes for cancer therapy.
    Kontermann RE
    Curr Opin Mol Ther; 2006 Feb; 8(1):39-45. PubMed ID: 16506524
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immunoliposomes directed toward VCAM-1 interact specifically with activated endothelial cells--a potential tool for specific drug delivery.
    Voinea M; Manduteanu I; Dragomir E; Capraru M; Simionescu M
    Pharm Res; 2005 Nov; 22(11):1906-17. PubMed ID: 16088429
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antibody derivatization and conjugation strategies: application in preparation of stealth immunoliposome to target chemotherapeutics to tumor.
    Manjappa AS; Chaudhari KR; Venkataraju MP; Dantuluri P; Nanda B; Sidda C; Sawant KK; Murthy RS
    J Control Release; 2011 Feb; 150(1):2-22. PubMed ID: 21095210
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of surface displayed targeting ligand GE11 on liposome distribution and extravasation in tumor.
    Tang H; Chen X; Rui M; Sun W; Chen J; Peng J; Xu Y
    Mol Pharm; 2014 Oct; 11(10):3242-50. PubMed ID: 25181533
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A targeted liposome delivery system for combretastatin A4: formulation optimization through drug loading and in vitro release studies.
    Nallamothu R; Wood GC; Kiani MF; Moore BM; Horton FP; Thoma LA
    PDA J Pharm Sci Technol; 2006; 60(3):144-55. PubMed ID: 17089683
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Anti-HER2 immunoliposomes for targeted therapy of human tumors.
    Park JW; Hong K; Kirpotin DB; Meyer O; Papahadjopoulos D; Benz CC
    Cancer Lett; 1997 Oct; 118(2):153-60. PubMed ID: 9459205
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Integrinβ6-targeted immunoliposomes mediate tumor-specific drug delivery and enhance therapeutic efficacy in colon carcinoma.
    Liang B; Shahbaz M; Wang Y; Gao H; Fang R; Niu Z; Liu S; Wang B; Sun Q; Niu W; Liu E; Wang J; Niu J
    Clin Cancer Res; 2015 Mar; 21(5):1183-95. PubMed ID: 25549721
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Characterization of in vivo immunoliposome targeting to pulmonary endothelium.
    Maruyama K; Holmberg E; Kennel SJ; Klibanov A; Torchilin VP; Huang L
    J Pharm Sci; 1990 Nov; 79(11):978-84. PubMed ID: 2292774
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Building and characterizing antibody-targeted lipidic nanotherapeutics.
    Kirpotin DB; Noble CO; Hayes ME; Huang Z; Kornaga T; Zhou Y; Nielsen UB; Marks JD; Drummond DC
    Methods Enzymol; 2012; 502():139-66. PubMed ID: 22208985
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A mathematical model of the enhanced permeability and retention effect for liposome transport in solid tumors.
    Stapleton S; Milosevic M; Allen C; Zheng J; Dunne M; Yeung I; Jaffray DA
    PLoS One; 2013; 8(12):e81157. PubMed ID: 24312530
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Single chain anti-c-Met antibody conjugated nanoparticles for in vivo tumor-targeted imaging and drug delivery.
    Lu RM; Chang YL; Chen MS; Wu HC
    Biomaterials; 2011 Apr; 32(12):3265-74. PubMed ID: 21306768
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Preparation and evaluation of paclitaxel-loaded PEGylated immunoliposome.
    Yang T; Choi MK; Cui FD; Kim JS; Chung SJ; Shim CK; Kim DD
    J Control Release; 2007 Jul; 120(3):169-77. PubMed ID: 17586082
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.